CG_Financial

BMY Long Term Long

Alış
NYSE:BMY   Bristol-Myers Squibb Company
Healthy pipeline.

Sitting at 3.32% yield and 8.62 P/E (norm is 18.65 and 5Y norm is 11.17) with earnings growth rate approx. 6.18% since 2000 but has increased to 15-16% if you look at the 10Y and 5Y norms.

Estimates are for about 4-6% the next 2 years.

A+ Credit Rating
48LT Debt to Cap

PT $96 by 2023 using a 7% earnings growth rate and 12 P/E

HUGE saucer pattern -- technically.
Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.